ClinicalTrials.Veeva

Menu

Natural History of Atherosclerosis

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Atherosclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT00918541
CarotidMRI

Details and patient eligibility

About

20 patients will be recruited. The aim of the study is to determine the natural progression of atherosclerotic disease.

Enrollment

30 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stable carotid artery disease not requiring revascularization
  • asymptomatic carotid artery stenosis < 80% or symptomatic patients with stenosis < 60 %
  • prophylactic therapy with aspirin (> 100mg/day, statin, blood pressure therapy if indicated (goal < 130/80 mmHg))
  • informed consent

Exclusion criteria

  • non atherosclerotic occlusive disease (Bürgers disease)
  • uncontrolled BP (DBP > 110 mmHg and/or SBP > 200 mmHg)
  • hemorrhagic disease or platelet count < 100'000 mm^3
  • Known active liver disease (elevations of GPT GOT or increased ammonia)
  • impaired renal function (crea > 180 mmol/l)
  • pregnancy
  • severe claustrophobic reactions
  • short - term life - threatening pathology
  • physically unable to participate in the study
  • compliance not guaranteed

Trial design

30 participants in 1 patient group

A
Description:
asymptomatic patients with mild to moderate carotid artery stenosis

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems